Literature DB >> 12746770

Imported Lassa fever in Germany: surveillance and management of contact persons.

Walter H Haas1, Thomas Breuer, Günter Pfaff, Herbert Schmitz, Päivi Köhler, Marcel Asper, Petra Emmerich, Christian Drosten, Uta Gölnitz, Klaus Fleischer, Stephan Günther.   

Abstract

This study sought to assess the risk of secondary transmission after import of Lassa fever into Europe. A total of 232 persons exposed to a case of Lassa fever imported into Germany were identified. The level of exposure was determined for 157 persons (68%), and 149 (64%) were tested serologically. High-risk or close contact was reported by 30 (19%) of 157 persons. No symptomatic secondary infections were observed. However, Lassa virus-specific immunoglobulin G antibodies were detected in a serum sample obtained from a physician who examined the index patient on day 9 of illness. The physician received ribavirin prophylaxis and did not develop symptoms of Lassa fever. On the basis of these data, the contact was classified as having a probable secondary infection. The study indicates a low risk of transmission during the initial phase of symptomatic Lassa fever, even with high-risk exposures. The risk may increase with progression of disease and increasing virus load.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746770     DOI: 10.1086/374853

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  66 in total

1.  Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding.

Authors:  Kathryn M Hastie; Tong Liu; Sheng Li; Liam B King; Nhi Ngo; Michelle A Zandonatti; Virgil L Woods; Juan Carlos de la Torre; Erica Ollmann Saphire
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.

Authors:  Stephan Olschläger; Michaela Lelke; Petra Emmerich; Marcus Panning; Christian Drosten; Meike Hass; Danny Asogun; Deborah Ehichioya; Sunday Omilabu; Stephan Günther
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression.

Authors:  Kathryn M Hastie; Christopher R Kimberlin; Michelle A Zandonatti; Ian J MacRae; Erica Ollmann Saphire
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

5.  Lassa fever - full recovery without ribavarin treatment: a case report.

Authors:  Nnennaya A Ajayi; Kingsley N Ukwaja; Ngozi A Ifebunandu; Richard Nnabu; Francis I Onwe; Danny A Asogun
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

6.  Myristoylation of the Arenavirus Envelope Glycoprotein Stable Signal Peptide Is Critical for Membrane Fusion but Dispensable for Virion Morphogenesis.

Authors:  Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

7.  Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors.

Authors:  Kim Long Yeo; Yen-Liang Chen; Hao Ying Xu; Hongping Dong; Qing-Yin Wang; Fumiaki Yokokawa; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

8.  Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.

Authors:  Sundaresh Shankar; Landon R Whitby; Hedi E Casquilho-Gray; Joanne York; Dale L Boger; Jack H Nunberg
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

9.  T cell-dependence of Lassa fever pathogenesis.

Authors:  Lukas Flatz; Toni Rieger; Doron Merkler; Andreas Bergthaler; Tommy Regen; Mariann Schedensack; Lukas Bestmann; Admar Verschoor; Mario Kreutzfeldt; Wolfgang Brück; Uwe-Karsten Hanisch; Stephan Günther; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

10.  Response to imported case of Marburg hemorrhagic fever, the Netherland.

Authors:  Aura Timen; Marion P G Koopmans; Ann C T M Vossen; Gerard J J van Doornum; Stephan Günther; Franchette van den Berkmortel; Kees M Verduin; Sabine Dittrich; Petra Emmerich; Albert D M E Osterhaus; Jaap T van Dissel; Roel A Coutinho
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.